Showing results (761-770 of 859) with videos related to

Sort By:
Pageof 86
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 26, 2025
Modulation of Brain Temporal Complexity During Treatment for Depression: A CAN-BIND-1 Study Report: Modulation de la complexité temporelle du cerveau pendant le traitement de la dépression: rapport de l'étude CAN-BIND-1Chloé Stengel, Benjamin Schwartzmann, Raaj Chatterjee, et al.
Journal of Affective Disorders|June 12, 2024
Depression-Anxiety Coupling Strength as a predictor of relapse in major depressive disorder: A CAN-BIND wellness monitoring study reportAbraham Nunes, Barbara Pavlova, Jasmyn E A Cunningham, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|January 15, 2022
Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A Canadian Biomarker Integration Network for Depression StudyPrabhjot Dhami, Lena C Quilty, Benjamin Schwartzmann, et al.
Psychological Medicine|October 10, 2007
Measuring depression: comparison and integration of three scales in the GENDEP studyR Uher, A Farmer, W Maier, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 30, 2025
Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Prédire la rechute d'épisodes dépressifs pendant le traitement d'entretien : Une étude de suivi du bien-être dans les troubles dépressifs majeurs du Réseau canadien d'intégration des biomarqueurs pour la dépression (CAN-BIND)Raymond W Lam, Katerina Rnic, John-Jose Nunez, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 20, 2013
Genome-wide association study of co-occurring anxiety in major depressionAlexandra Schosser, Amy W Butler, Rudolf Uher, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 3, 2012
Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levelsStefan Kloiber, Stephan Ripke, Martin A Kohli, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 22, 2023
Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trialsSarah R Vreijling, Cherise R Chin Fatt, Leanne M Williams, et al.
Brain : a Journal of Neurology|August 29, 2023
Prognostic value of single-subject grey matter networks in early multiple sclerosisVinzenz Fleischer, Gabriel Gonzalez-Escamilla, Deborah Pareto, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Association between neoadjuvant paclitaxel dose intensity and outcomes in early triple-negative and HER2-positive breast cancer: a real-world data analysisC van Marcke, K Pogoda, H Fenton, et al.
Pageof 86